KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/07/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization427,332 mln
Float22.70 mln
EPS
237
Stretched
P / E
58.88
Richly valued
Beneish M-Score
-0.68
Highly suspicious
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
Pre-Tax Margin
23%
Healthy margin
Business Description
Onconic Therapeutics is a South Korean pharmaceutical company focused on developing new treatments for cancer and digestive diseases. Founded in 2020 and headquartered in Seoul, the company is advancing several drug candidates, including a stomach acid treatment currently in late-stage clinical trials and a pancreatic cancer drug in early-stage testing. Its broader research efforts also target the body's DNA repair pathways and the use of the immune system to fight cancer.
